Glycans in Diseases and Therapeutics

Glycomedicine plays major role in cell-cell adhesion i.e. a method used by cells of the immune system via sugar-binding proteins called lectins, which identifies specific carbohydrate moieties. Glycan’s (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play major roles in many biological phenomena as well as in various pathophysiological processes. Many scientists in other fields of research have now realized that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is an important field of research and sometimes they require a glycobiology and/or glycochemistry approach to be used.

  • Congenital disorders of glycosylation (CDG)
  • Cardiovascular diseases
  • Cancer biomarkers
  • Cancer associated coagulopathies
  • Transfusion medicine
  • Cardiac arrest
  • Glycomedicine

Related Conference of Glycans in Diseases and Therapeutics

October 30 - 31, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 8-9, 2017

International Summit on Nanotechnology and Medical Robots

New Orleans, Louisiana, USA
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
March 12-14, 2018

Glycobiology Biochem Conference 2018

Paris, France
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany

Glycans in Diseases and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in